Randomised controlled trial of treating dysfunctional breathing to reduce breathlessness in severe asthma

ISRCTN ISRCTN92818360
DOI https://doi.org/10.1186/ISRCTN92818360
Secondary identifying numbers N0226167744
Submission date
29/09/2006
Registration date
29/09/2006
Last edited
12/05/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Rob Niven
Scientific

North West Lung Centre
South Manchester University Hospitals NHS Trust
Wythenshawe Hospital
Southmoor Road
Manchester
M23 9LT
United Kingdom

Phone +44 (0)161 291 2846
Email Robert.Niven@smuht.nwest.nhs.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific titleRandomised controlled trial of treating dysfunctional breathing to reduce breathlessness in severe asthma
Study objectivesTo improve thoraco-abdominal co-ordination and hence reduce breathlessness.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedRespiratory: Asthma
Intervention1. Patients will undergo breathing retraining with senior physiotherapist
2. Control
Intervention typeOther
Primary outcome measureChange in University of California San Diego Shortness-of-Breath Questionnaire (SOBQ) score after treatment for dysfunctional breathing
Secondary outcome measuresNot provided at time of registration
Overall study start date06/04/2004
Completion date15/12/2005

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants31
Key inclusion criteria31 patients suffering from severe asthma:
1. Patients with diagnosis of asthma requiring regular maintenance medication (that includes high dose inhaled corticosteroid and long-acting Β2 agonist)
2. High medical resource usage
3. Non-smoker for at least one year
4. Historical evidence of reversibility
Key exclusion criteria1. Previous treatment for hyperventilation, dysfunctional breathing, or other functional disorder of respiratory mechanics
2. Participation in another trial involving respiratory intervention
3. Current or recent lower respiratory tract infection
4. Presence of other respiratory diseases
5. DLCO <70% predicted, significant co-morbid illness
6. Pregnancy or nursing mother
7. Psychiatric disorder
8. Hospitalisation for asthma within the prior 6 weeks
Date of first enrolment06/04/2004
Date of final enrolment15/12/2005

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

North West Lung Centre
Manchester
M23 9LT
United Kingdom

Sponsor information

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

South Manchester University Hospitals NHS Trust (UK) NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan